Marksans Pharma Dividende
Dividende contrôle des critères 2/6
Marksans Pharma is a dividend paying company with a current yield of 0.21% that is well covered by earnings.
Informations clés
0.2%
Rendement du dividende
0.05%
Rendement des rachats
| Rendement total pour l'actionnaire | 0.3% |
| Rendement futur des dividendes | 1.2% |
| Croissance des dividendes | 5.2% |
| Prochaine date de paiement du dividende | n/a |
| Date ex-dividende | n/a |
| Dividende par action | ₹0.600 |
| Ratio de distribution | 9% |
Mises à jour récentes des dividendes
Recent updates
Is Now The Time To Put Marksans Pharma (NSE:MARKSANS) On Your Watchlist?
Oct 24
Optimistic Investors Push Marksans Pharma Limited (NSE:MARKSANS) Shares Up 45% But Growth Is Lacking
Sep 21Marksans Pharma Limited (NSE:MARKSANS) Stock Rockets 26% But Many Are Still Ignoring The Company
Jul 28Solid Earnings May Not Tell The Whole Story For Marksans Pharma (NSE:MARKSANS)
Jun 07Does Marksans Pharma (NSE:MARKSANS) Deserve A Spot On Your Watchlist?
May 31Sentiment Still Eluding Marksans Pharma Limited (NSE:MARKSANS)
Feb 16Here's Why Marksans Pharma (NSE:MARKSANS) Has Caught The Eye Of Investors
Jan 26We Think Marksans Pharma (NSE:MARKSANS) Can Manage Its Debt With Ease
Dec 02Marksans Pharma (NSE:MARKSANS) Seems To Use Debt Quite Sensibly
Jun 21Robust Earnings May Not Tell The Whole Story For Marksans Pharma (NSE:MARKSANS)
Nov 17This Is The Reason Why We Think Marksans Pharma Limited's (NSE:MARKSANS) CEO Deserves A Bump Up To Their Compensation
Sep 16Marksans Pharma (NSE:MARKSANS) Is Increasing Its Dividend To ₹0.25
Sep 01Marksans Pharma (NSE:MARKSANS) Could Easily Take On More Debt
Jun 14Is Now The Time To Put Marksans Pharma (NSE:MARKSANS) On Your Watchlist?
May 27Is Marksans Pharma (NSE:MARKSANS) A Risky Investment?
Feb 19Marksans Pharma Limited's (NSE:MARKSANS) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Feb 04Here's Why We Think Marksans Pharma (NSE:MARKSANS) Is Well Worth Watching
Jan 20Do Institutions Own Marksans Pharma Limited (NSE:MARKSANS) Shares?
Jan 05
Shareholders Are Thrilled That The Marksans Pharma (NSE:MARKSANS) Share Price Increased 250%
Dec 21What Can We Conclude About Marksans Pharma's (NSE:MARKSANS) CEO Pay?
Dec 06These 4 Measures Indicate That Marksans Pharma (NSE:MARKSANS) Is Using Debt Safely
Nov 19Stabilité et croissance des paiements
Récupération des données sur les dividendes
Dividende stable: MARKSANS's dividend payments have been volatile in the past 10 years.
Dividende croissant: MARKSANS's dividend payments have increased over the past 10 years.
Rendement des dividendes par rapport au marché
| Marksans Pharma Rendement des dividendes par rapport au marché |
|---|
| Segment | Rendement du dividende |
|---|---|
| Entreprise (MARKSANS) | 0.2% |
| 25% du marché (IN) | 0.2% |
| 25% du marché (IN) | 1.1% |
| Moyenne du secteur (Pharmaceuticals) | 0.7% |
| Analyste prévisionnel (MARKSANS) (jusqu'à 3 ans) | 1.2% |
Dividende notable: MARKSANS's dividend (0.21%) isn’t notable compared to the bottom 25% of dividend payers in the Indian market (0.24%).
Dividende élevé: MARKSANS's dividend (0.21%) is low compared to the top 25% of dividend payers in the Indian market (1.09%).
Bénéfice distribué aux actionnaires
Couverture des revenus: With its low payout ratio (8.7%), MARKSANS's dividend payments are thoroughly covered by earnings.
Paiement en espèces aux actionnaires
Couverture des flux de trésorerie: With its high cash payout ratio (126.1%), MARKSANS's dividend payments are not well covered by cash flows.